ArticleDiabetologia2025

Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register - an IMI-SOPHIA study.

Martin Heni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.